Literature DB >> 16733857

Effects of adacolumn selective leukocytapheresis on plasma cytokines during active disease in patients with active ulcerative colitis.

Hiroyuki Hanai1, Takayuki Iida, Masami Yamada, Yoshihiko Sato, Ken Takeuchi, Tatsuo Tanaka, Kenji Kondo, Masataka Kikuyama, Yasuhiko Maruyama, Yasushi Iwaoka, Akiko Nakamura, Kazuhisa Hirayama, Abby R Saniabadi, Fumitoshi Watanabe.   

Abstract

AIM: To investigate the relationship between ulcerative colitis (UC) clinical activity index (CAI) and circulating levels of IL-1ra, IL-10, IL-6 and IL-18.
METHODS: Blood levels of IL-1ra, IL-10, IL-6 and IL-18 were measured in 31 patients with active UC, the mean CAI was 11.1, ranging from 5-25; and 12 healthy individuals as controls. Patients were given granulocyte and monocyte adsorptive apheresis (GMA) with Adacolumn. Leucocytes which bear the FcgammaR and complement receptors were adsorbed to the column leucocytapheresis carriers. Each patient could receive up to 11 GMA sessions over 8 wk.
RESULTS: We found strong correlations between CAI and IL-10 (r = 0.827, P < 0.001), IL-6 (r = 0.785, P < 0.001) and IL-18 (r = 0.791, P < 0.001). IL-1ra was not correlated with CAI. Following GMA therapy, 24 of the 31 patients achieved remission and the levels of all 4 cytokines fell to the levels in healthy controls. Further, blood levels of IL-1ra and IL-10 increased at the column outflow and inflow at 60 min suggesting release from leucocytes that adhered to the carriers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16733857      PMCID: PMC4087871          DOI: 10.3748/wjg.v12.i21.3393

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  57 in total

Review 1.  The role of IL-18 in innate immunity.

Authors:  S Akira
Journal:  Curr Opin Immunol       Date:  2000-02       Impact factor: 7.486

Review 2.  The key role of macrophages in the immunopathogenesis of inflammatory bowel disease.

Authors:  Y R Mahida
Journal:  Inflamm Bowel Dis       Date:  2000-02       Impact factor: 5.325

Review 3.  Role of cytokines in the pathogenesis of inflammatory bowel disease.

Authors:  K A Papadakis; S R Targan
Journal:  Annu Rev Med       Date:  2000       Impact factor: 13.739

4.  Neutrophil apoptosis is delayed in patients with inflammatory bowel disease.

Authors:  A E Brannigan; P R O'Connell; H Hurley; A O'Neill; H R Brady; J M Fitzpatrick; R W Watson
Journal:  Shock       Date:  2000-05       Impact factor: 3.454

Review 5.  Regulation of production of soluble Fc gamma receptors type III in normal and pathological conditions.

Authors:  I Moldovan; J Galon; I Maridonneau-Parini; S Roman Roman; C Mathiot; W H Fridman; C Sautès-Fridman
Journal:  Immunol Lett       Date:  1999-05-03       Impact factor: 3.685

6.  Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease.

Authors:  J A Tibble; G Sigthorsson; S Bridger; M K Fagerhol; I Bjarnason
Journal:  Gastroenterology       Date:  2000-07       Impact factor: 22.682

7.  Production of IL-1beta, IL-1 receptor antagonist and IL-10 by mononuclear cells from patients with SLE.

Authors:  L S Andersen; J Petersen; M Svenson; K Bendtzen
Journal:  Autoimmunity       Date:  1999       Impact factor: 2.815

8.  Colonic explant production of IL-1and its receptor antagonist is imbalanced in inflammatory bowel disease (IBD).

Authors:  S Dionne; I D D'Agata; J Hiscott; T Vanounou; E G Seidman
Journal:  Clin Exp Immunol       Date:  1998-06       Impact factor: 4.330

9.  A regulatory role for Fcgamma receptors CD16 and CD32 in the development of murine B cells.

Authors:  B de Andres; A L Mueller; S Verbeek; M Sandor; R G Lynch
Journal:  Blood       Date:  1998-10-15       Impact factor: 22.113

10.  Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis.

Authors:  Nobuhito Kashiwagi; Kazuhito Sugimura; Hirobumi Koiwai; Hironori Yamamoto; Toshikazu Yoshikawa; Abby R Saniabadi; Masakazu Adachi; Takashi Shimoyama
Journal:  Dig Dis Sci       Date:  2002-06       Impact factor: 3.199

View more
  17 in total

Review 1.  The mode of actions of the Adacolumn therapeutic leucocytapheresis in patients with inflammatory bowel disease: a concise review.

Authors:  H Hanai; Y Takeda; M Eberhardson; R Gruber; A R Saniabadi; O Winqvist; R Lofberg
Journal:  Clin Exp Immunol       Date:  2010-11-16       Impact factor: 4.330

Review 2.  Molecular fingerprints of neutrophil-dependent oxidative stress in inflammatory bowel disease.

Authors:  Yuji Naito; Tomohisa Takagi; Toshikazu Yoshikawa
Journal:  J Gastroenterol       Date:  2007-10-15       Impact factor: 7.527

3.  Reduction of dendritic cells by granulocyte and monocyte adsorption apheresis in patients with ulcerative colitis.

Authors:  Grit Waitz; Sebastian Petermann; Stefan Liebe; Joerg Emmrich; Wolfgang Ramlow
Journal:  Dig Dis Sci       Date:  2008-02-06       Impact factor: 3.199

Review 4.  Positions of selective leukocytapheresis in the medical therapy of ulcerative colitis.

Authors:  Hiroyuki Hanai
Journal:  World J Gastroenterol       Date:  2006-12-21       Impact factor: 5.742

Review 5.  Immunological Mechanisms of Adsorptive Cytapheresis in Inflammatory Bowel Disease.

Authors:  Esteban Sáez-González; Inés Moret; Diego Alvarez-Sotomayor; Francia Carolina Díaz-Jaime; Elena Cerrillo; Marisa Iborra; Pilar Nos; Belén Beltrán
Journal:  Dig Dis Sci       Date:  2017-04-21       Impact factor: 3.199

Review 6.  Treating inflammatory bowel disease by adsorptive leucocytapheresis: a desire to treat without drugs.

Authors:  Abbi R Saniabadi; Tomotaka Tanaka; Toshihide Ohmori; Koji Sawada; Takayuki Yamamoto; Hiroyuki Hanai
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

7.  Plasma osteopontin predicts inflammatory bowel disease activities.

Authors:  Shihoko Komine-Aizawa; Hideki Masuda; Takerou Mazaki; Motomi Shiono; Satoshi Hayakawa; Tadatoshi Takayama
Journal:  Int Surg       Date:  2015-01

8.  Granulo-monocyto apheresis is more effective in mild ulcerative colitis than in moderate to severe disease.

Authors:  Chiara De Cassan; Edoardo Savarino; Piero Marson; Tiziana Tison; Giorgia Hatem; Giacomo Carlo Sturniolo; Renata D'Incà
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

9.  Adsorptive depletion of alpha4 integrin(hi)- and CX3CR1hi-expressing proinflammatory monocytes in patients with ulcerative colitis.

Authors:  Shin-ichiro Takeda; Toru Sato; Tatsuro Katsuno; Tomoo Nakagawa; Yoshiko Noguchi; Osamu Yokosuka; Yasushi Saito
Journal:  Dig Dis Sci       Date:  2009-11-12       Impact factor: 3.199

10.  Selective Granulocyte and Monocyte Apheresis as a Non-Pharmacological Option for Patients with Inflammatory Bowel Disease.

Authors:  Gerda C Leitner; Nina Worel; Harald Vogelsang
Journal:  Transfus Med Hemother       Date:  2012-07-31       Impact factor: 3.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.